Literature DB >> 16216646

Bacteremias: a leading cause of death.

Gonzalo M L Bearman1, Richard P Wenzel.   

Abstract

Bloodstream infections (BSIs), recognized to be a major cause of morbidity and mortality globally, are increasing in incidence. The reported rates of crude and attributable mortality vary, possibly due to heterogeneity in patient populations and methodology. Few studies, however, have focused on pathogen-specific attributable mortality. These studies include S. aureus, coagulase-negative staphylococci and enterococcus. Other studies of attributable mortality have been conducted in select populations such as nosocomial and community-acquired cohorts, intensive care units, neutropenic patients, and HIV-positive patients. Regrettably, despite advances in treatment and intensive care facilities, mortality remains high.

Entities:  

Mesh:

Year:  2005        PMID: 16216646     DOI: 10.1016/j.arcmed.2005.02.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  71 in total

1.  Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci.

Authors:  Anne J M Loonen; Arjan R Jansz; Jeandery N B Bergland; Marion Valkenburg; Petra F G Wolffs; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Tuf gene sequence analysis has greater discriminatory power than 16S rRNA sequence analysis in identification of clinical isolates of coagulase-negative staphylococci.

Authors:  Sang Mee Hwang; Myoung Shin Kim; Kyoung Un Park; Junghan Song; Eui-Chong Kim
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

3.  Optimized pathogen detection with 30- compared to 20-milliliter blood culture draws.

Authors:  Robin Patel; Emily A Vetter; W Scott Harmsen; Cathy D Schleck; Hind J Fadel; Franklin R Cockerill
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

4.  Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting.

Authors:  Martin Christner; Holger Rohde; Manuel Wolters; Ingo Sobottka; Karl Wegscheider; Martin Aepfelbacher
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

5.  Appropriateness of blood culture testing parameters in routine practice. Results from a cross-sectional study.

Authors:  V Vitrat-Hincky; P François; J Labarère; C Recule; J P Stahl; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-18       Impact factor: 3.267

Review 6.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

Review 7.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia.

Authors:  Ryuzo Abe; Shigeto Oda; Tomohito Sadahiro; Masataka Nakamura; Yo Hirayama; Yoshihisa Tateishi; Koichiro Shinozaki; Hiroyuki Hirasawa
Journal:  Crit Care       Date:  2010-03-04       Impact factor: 9.097

9.  A pig model of acute Staphylococcus aureus induced pyemia.

Authors:  Ole L Nielsen; Tine Iburg; Bent Aalbaek; Páll S Leifsson; Jørgen S Agerholm; Peter Heegaard; Mette Boye; Sofie Simon; Kristine B Jensen; Sophie Christensen; Karin Melsen; Anne K Bak; Elín R Backman; Mia H Jørgensen; Désirée K Groegler; Asger L Jensen; Mads Kjelgaard-Hansen; Henrik E Jensen
Journal:  Acta Vet Scand       Date:  2009-03-27       Impact factor: 1.695

10.  Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system.

Authors:  A Lupetti; S Barnini; B Castagna; A-L Capria; P H Nibbering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.